It was reported through a research article identifying the herculink elite stent that may be related to the following: discomfort during balloon inflation, retroperitoneal hemorrhage, renal artery perforation, arterial and aortic dissection, atheromatous embolization, and renal infarctions.Specific patient information is documented as unknown.Details are listed in the attached article, titled "scai expert consensus statement for renal artery stenting appropriate use".
|
(b)(4).The devices are not returning and there was no reported device malfunction.Review of the lot history record could not be conducted because the lot numbers were not provided.The reported patient effects of dissection, embolism, hemorrhage, perforation, kidney infarct, and pain are known observed and potential patient effects as listed in the rx herculink elite instructions for use.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.Sahil a.Parikh,1 md, facc, fscai ; mehdi h.Shishehbor, do, mph, facc, fscai; bruce h.Gray, do, fscai; christopher j.White, md, facc, fscai and michael r.Jaff, do, facc, fscai.(catheterization and cardiovascular interventions 00:00-00 (2014)): scai expert consensus statement for renal artery stenting appropriate use.
|